Eventide Asset Management - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$2,838,000
-38.0%
336,2230.0%0.06%
-15.3%
Q1 2022$4,576,000
-30.8%
336,2230.0%0.07%
-15.3%
Q4 2021$6,614,000
-65.7%
336,223
-44.0%
0.08%
-66.5%
Q3 2021$19,260,000
-5.2%
600,0000.0%0.25%
-7.0%
Q2 2021$20,310,000
-9.9%
600,0000.0%0.27%
-18.3%
Q1 2021$22,536,000
+13.1%
600,0000.0%0.33%
+9.2%
Q4 2020$19,932,000
+20.8%
600,000
+33.3%
0.31%
-5.3%
Q3 2020$16,502,000
+11.4%
450,0000.0%0.32%
+0.3%
Q2 2020$14,809,000
+27.5%
450,0000.0%0.32%
-14.4%
Q1 2020$11,619,000
-17.1%
450,0000.0%0.38%
-4.8%
Q4 2019$14,013,000450,0000.40%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,760,869$39,000,21212.45%
Frazier Life Sciences Management, L.P. 10,109,279$104,833,2236.96%
Decheng Capital Management III (Cayman), LLC 850,000$8,814,5002.94%
Carlyle Group Inc. 3,496,808$36,191,9631.57%
Ghost Tree Capital, LLC 395,000$4,096,1501.35%
Newtyn Management, LLC 500,000$5,185,0001.28%
Altium Capital Management LP 220,000$2,281,4001.19%
StepStone Group LP 422,085$4,377,0210.98%
MPM BioImpact LLC 347,332$3,601,8330.96%
NEA Management Company, LLC 1,276,595$12,238,2900.94%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders